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dSurgical aortic valve replacement (AVR) is the treatment ofchoice for patients with severe symptomatic aortic steno-
is. The major drawbacks of the traditional surgical approach
nclude its invasiveness, typically requiring a sternotomy,
nd always requiring cardiopulmonary bypass. These com-
onents are the principal impediments when treating the
xtremely elderly, frail, or high-risk patients.
Transapical transcatheter aortic valve implantation (TA-
AVI), a minimally invasive, beating heart surgical treatment
or severe aortic stenosis, is an alternative for the traditional
VR technique. The TA-TAVI is presently investigational in
he United States (in the Placement of AoRTic TraNscathetER
alve Trial—PARTNER trial) and is already commercially
vailable in Europe and other parts of the world. Although
here are other investigational devices in various stages of
evelopment, the only widely available and used TA-TAVI
evice is the Edwards SAPIEN valve (Edwards Lifesciences
nc., Irvine, CA).
Key factors for a successful TA-TAVI are proper patient
creening and selection, accurate intraprocedural multimo-
ality imaging, and surgeon familiarity with catheter-based
kill set. As such, TA-TAVI should be performed with the
ollaboration of surgeons, interventional cardiologists, and
nesthesiologists in a hybrid operating room (OR) suite
quipped with high-definition, fixed imaging systems and
vailable surgical “bail out” equipment.
In addition to fluoroscopy, transesophageal echocardiog-
aphy (TEE) provides crucial real-time information on sizing
he aortic annulus, sinotubular junction diameter, coronary
stia height, and valve and root calcification and enables safer
alve deployment along with immediate post implantation
ssessment of the new prosthesis as well as the cardiac func-
ion.
The cardiopulmonary bypass team and apparatus must be
repared on site for abrupt bypass initiation either peripher-
lly or centrally. Moreover, highly skilled nursing personnel
ualified for the hybrid OR environment will improve safety
nd fluency of the procedure.
This device is a balloon expandable stent with bovine peri-
ardium utilized for the leaflet tissue. Currently available
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doi:10.1053/j.optechstcvs.2010.12.004izes are 23 mm and 26 mm, suitable for patients with a
easured annulus between 18 mm and 25 mm. Valve size
election [based mainly on preprocedural TEE measure-
ents of the annulus] requires oversizing of the annular di-
meter so that patients with aortic annulus of 21 mm or less
ill get the 23-mm prosthesis, whereas those with a mea-
ured annulus larger than 21 mm will receive the larger
6-mm Sapien valve. The device is only suitable for patients
ith aortic stenosis (and perhaps degenerative bioprosthet-
cs) as the presence of calcium in the valve is required for it to
nchor in place.
Additional anatomic considerations are the coronary ostia
nd sinotubular junction (STJ) distance (height) from the
nnulus and the STJ diameter. Coronary ostia height of more
han 10 mm (for either valve size), an STJ height of more than
8 mm (for either valve size), and an STJ diameter of 21 mm
or the 23 valve and 24 mm for the 26 valve are the ideal
imensions required for safe deployment of the current pros-
heses.
Preoperative computed tomography and magnetic reso-
ance imaging may be useful for additional validation of the
bove estimates but may overestimate true annulus size;
oreover, most operators are not yet sufficiently familiar
ith these imaging modalities to measure the above dimen-
ions.
Potential drawbacks of this valve include the inability to
eposition or recapture the valve once it is deployed, the high
ncidence of paravalvular aortic insufficiency, and unknown
urability. Specific considerations to the transapical ap-
roach include instrumentation of the apex of the heart and
otential for catastrophic complications should closure of the
pex be unsuccessful. As in all surgical procedures, careful
creening of the patient remains absolutely mandatory. Al-
hough this procedure is less invasive and perhaps better
olerated than a surgical AVR in some high-risk patients, it is
ot necessarily appropriate for all patients. Indeed, there are
ome patients that are perhaps too frail and debilitated with
dvanced disease that sadly will not benefit from any therapy.
In conclusion, transapical aortic valve implantation repre-
ents a new and exciting procedure for cardiac surgeons. In
ddition to the transfemoral approach, TA-TAVI provides a
nique paradigm for cardiac surgeons and interventional car-
iologists to collaborate closely for the benefit of our patients.
Room Setup
Figure 1 is an illustration of a hybrid OR setup for a TA-TAVI.
The primary operator is situated on the left side of the patient.
41
. TEE
42 Y. Ben-Gal and M. WilliamsAnother operator is situated across on the right or adjacent to
the primary operator to aid in management of the apex and
sheath stability. Other operators are also present to aid in
wire management and balloon deployment. In all cases these
Figure 1 Hybrid OR setup for TA-AVIoperators should represent a combination of cardiac sur-geons and interventional cardiologists. The roles can be
switched, although apical closure should be performed by a
skilled surgeon. The “layout” and the “roles” of all personnel
should be planned before the start of the procedure. Addi-
 transesophageal echocardiograph.tionally, availability of equipment for all possible adverse
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Transapical transcatheter aortic valve implantation 43events should be prepared and rehearsed. Well-trained “hy-
brid” nursing staff will ensure an uninterrupted, well-coordi-
nated procedure.
Room Stations
1. Fixed wide-field image intensifier injector should be
loaded with saline-diluted radio-opaque solution (1:1
ratio).
2. TEE station.
3. Cardiopulmonary bypass station.
4. Anesthesia station (equipped with a pacemaker and
defibrillator).
5. Device preparation and crimping station.
Positioning
Patient’s positioning is as follows: the intubated patient is
positioned in the supine position exposing the entire chest
(up to the left mid axillary line on the left side) and both
groins (Figs. 2 and 3). Although the patient can be slightly
otated with the left side up, we have found this unnecessary
nd it tends to alter preplanned deployment angles of the
maging system. Double lumen intubation is not required. If
he left lung is in the field (rarely the case), it can easily be
isplaced with a moist surgical pad. Surgical draping is over-
apped by a catheterization drape from the groins downward.
adiolucent defibrillator pads are attached to right anterior
xillary line and to lower border of left scapula.
An infra-mammary surgical incision (4 cm to 8 cm in
ength) is performed above the point of maximal impulse
typically in the fifth to sixth intercostal space). Fluoroscopic
isualization of a clamp placed above the estimated cardiac
pex also can help facilitate appropriate incision location
Figs. 4A and B). Vascular sheaths are inserted to the com-
on femoral artery (5 French) and vein (6 French). These
Figure 2 Paheaths are used for a transvenous pacer (epicardial pacingmay also be used) and a pigtail catheter for imaging. These
access sites can also be used for cannulation in the event of an
emergency requiring the initiation of cardiopulmonary by-
pass.
In the case of high concern or due to operator comfort,
the femoral vessels may be surgically exposed to facilitate
rapid cardiopulmonary bypass cannulation in the event of
an emergency. It should, however, be noted that patients
undergoing TA-TAVI typically have poor iliofemoral ac-
cess vessels and in extreme cases peripheral cannulation
may not even be feasible. In these situations possible al-
ternatives include exposure of the axillary artery, extend-
ing the thoracotomy for descending aortic cannulation,
sternotomy with ascending aortic cannulation, or even
apical cannulation in extreme cases.
Fluoroscopic Working-
Plane Determination,
Placement of Pacemaker
Root Shot
Aortic root fluoroscopy during contrast material injection
(“root shot”) is performed to determine the final deployment
view. Ideally this angle will be known from prior diagnostic
studies. The image intensifier plane should be perpendicular
to the aortic annulus plane in a way such that the 3 “hinge
points” defined by the bottom of the sinuses are all in the
same plane and equally visible (Fig. 4C). A shallow left ante-
rior oblique (15%) and cranial (15%) or right anterior
oblique (10%) and caudal (20%) are common views in which
the correct fluoroscopy plane can be achieved with minimal
limitation of the surgeon’s ability to maneuver. Avoid using
calcification as sole reference point for the annulus because
dense calcium is found most frequently on the leaflet itself
ositioning.and above the annulus.
44 Y. Ben-Gal and M. WilliamsFigure 3 Patient draping and positioning.
Transapical transcatheter aortic valve implantation 45Figure 4 (A, B) Fluoroscopic estimation of cardiac apex location. (C) Aortic “root shot” for appropriate deployment view.
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46 Y. Ben-Gal and M. WilliamsPacemaker Insertion
A transvenous pacemaker (TVP) is inserted into the right
ventricle through the femoral venous sheath; alternatively,
TVP can be inserted through the jugular port or can be per-
formed directly with epicardial leads. Brief pacing interlude
will validate proper capture and position.
Procedure: Surgical
Exposure and Site Preparation
Exposure
A left anterior thoracotomy is performed through the fifth or
sixth intercostals space with positioning of a soft-tissue retractor
in the selected intercostal space (Fig. 5).
The pericardium is opened and retracted with pericardial
stitches (Fig. 6); these should ideally be secured to the skin
and tied rather than using clamps that are radio-opaque. A
small rigid retractor can be used if exposure is not adequate
or to allow more space for placement of the apical sutures
(Fig. 7). The ideal location is not in the true apex but rather
lateral to the left anterior descending coronary artery and
toward the base (Fig. 8). In most patients there is an area that
is free of fat at this location. Two 2-0 polypropylene purse-
string sutures with large needles (v-26) and pledgets on every
bite should be used. Each “bite” of the cardiac muscle should
be very deep. Although full thickness is not necessary, it is
Figure 5 Left anbetter to be full thickness than too shallow (Fig. 9). The ipattern of the sutures is at the discretion of the surgeon and is
frequently limited by the size of the incision. We typically
prefer either 3 bites with every suture or even 2 perpendicu-
lar horizontal mattress sutures. Reoperations rarely pose any
problem and it is not even necessary to dissect the pericar-
dium off the heart provided the operator is certain the sutures
are not involving the left anterior descending coronary artery
and septum (Fig. 10A).
Apical Access
Before accessing the apex, the Ascendra balloon valvulo-
plasty catheter (Fig. 10B) is prepared and the appropriate
sized THV-Sapien valve is crimped over the Ascendra balloon
catheter–valve deployment system (Fig. 10C). Remember,
accurate valve position on the catheter must be verified (with
he green suture line located in the proximal aspect of the
alve and away from the catheter tip; Fig. 11).
With the image intensifier positioned in the predeter-
ined deployment angle and under fluoroscopy guidance, a
eedle is inserted within the middle of the purse-string su-
ures into the cardiac apex aimed toward the right shoulder
Fig. 12) and a 180-cm soft J-wire is steered through the left
entricle into the aortic arch and abdominal aorta (Fig. 13). A
-French hydrophilic catheter or a right Judkins catheter
ay ease the steering process of the J-wire in the aortic arch
sing its angled tip to direct the wire away from the innom-
thoracotomy.teriornate artery.
Transapical transcatheter aortic valve implantation 47Once the J-wire is positioned in the descending aorta, the
catheter is fully advanced over the wire into the abdominal
aorta to enable safe exchange of the J-wire to a stiffer wire.
Placement of any sheath for this part of the procedure is not
necessary. The mitral valve should be closely examined with
TEE to confirm the stiff wire is not through the mitral appa-
ratus or causing severe mitral regurgitation. If this occurs, the
wire should be repositioned as it is unlikely the valve will be
able to be advanced if it is caught in these structures.
Procedure: Valvuloplasty
The Ascendra introducer sheath system (Fig. 14A and B) is
Figure 6 Soft tissue retractoradvanced over the wire 4 to 5 cm deep (Fig. 14C), into theleft ventricle facing the aortic valve. White color markings
near the sheath tip will guide proper depth of insertion,
while on the fluoroscopy monitor the sheath radio-opaque
tip can also be visualized 4 to 5 cm away from the aortic
annulus.
The dilator is then retrieved and the sheath is de-aired and
flushed through side arm while the Ascendra balloon valvu-
loplasty catheter (20 mm) is advanced through the sheath
into the aortic valve (Fig. 10B). At the discretion of the oper-
ator, a traditional valvuloplasty balloon may also be used,
although this requires the use of an exchange length wire.
Proper balloon positioning is facilitated by the 2 radio-
opaque markers on the balloon tips that should be equal
ericardial traction stitches.and pdistance from the annular plane (Fig. 15A; BAV in position.
48 Y. Ben-Gal and M. WilliamsWhite arrow points to the annular plane in between the bal-
loon’s radio-opaque borders).
Once the balloon is positioned, rapid ventricular pacing is
initiated (170-210 bpm) to reduce blood and pulse pressure
(mean, 40 mm Hg). When the pressure target is achieved,
the balloon is fully inflated (Fig. 15B) and then deflated and
pacing is quickly discontinued (Fig. 16; monitor tracing’s
during valvuloplasty: A, pacing and diminution of blood
pressures; B, balloon inflation; C, balloon deflation; D, pac-
ing cessation). Pacing is not absolutely required for the val-
vuloplasty but it serves as a good “dry run” for the actual valve
deployment.
Figure 7 It is possible tAppropriate valvuloplasty is characterized by a stable im-mobile balloon position. If the valvuloplasty causes severe
aortic insufficiency with resulting hemodynamic instability,
the team should move very quickly to place the transcatheter
valve as this is the only quick treatment of aortic insuffi-
ciency.
In the event of a low coronary orifice, narrow STJ, or heav-
ily calcified cusps, it is possible to inject contrast through the
pigtail (in a left anterior oblique 20= cranial 10= position)
during balloon inflation to verify adequate coronary flow (for
future valve deployment).
The assistant surgeon secures the stable position of the
sheath in the apex, and while the surgeon is positioning the
small rigid retractor.o add aballoon, another operator inflates the balloon.
Transapical transcatheter aortic valve implantation 49The surgeon or other primary operator is responsible for
directing team members in proper balloon positioning, pac-
ing initiation, balloon inflation, balloon deflation, and pacing
discontinuation.
Valve Deployment
The balloon is retrieved and the valve loader (protecting
the crimped valve inside; Fig. 17) is locked into the intro-
ducer sheath (Fig. 18). The valve is pushed into the cath-
eter and the system is de-aired. The valve is advanced until
it exits the sheath (Fig. 19). The white support rod is then
pulled back and locked. If the valve should cross too far
Figure 8 Purse-string position on cardiac apeinto the aorta beyond the valve, it is important that this rodbe advanced back to the valve to support it during pull
back across the valve. It should then be retracted again
before positioning and deployment. The valve is then ad-
vanced carefully to the mid plane of aortic cusp hinge
point, such that 50% of the valve is on the ventricular side
of the annulus and 50% is on the aortic side (Fig. 20).
Using both root shots and TEE guidance, fine adjustments
can be made by slight inward/outward maneuvers of the
catheter. Additionally, inward or backward maneuvers of
the wire can help locate the valve so it is in a more ideal
coaxial plane with the valve.
If there is significant movement of the valve with the car-
diac cycle, an aortogram can be performed during short rapid
 left anterior descending coronary artery.x. LADpacing intervals, to clarify where the valve will deploy.
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50 Y. Ben-Gal and M. WilliamsSufficient time should be allowed and all the measures
taken to assure proper positioning, as simple retrievability is
not an option after valve deployment.
When a satisfactory position is reached, the pigtail should be
pulled to the arch, and pacing can be initiated. The valve balloon
inflation should be forceful but not rapid and only after full
acing captures the diminished blood and pulse pressures
same as for the valvuloplasty previously performed). After 3 to
seconds of complete expansion, the balloon is fully deflated
nd pacing is terminated only after the balloon has completely
ollapsed (Fig. 21; valve deployment stages).
Post Deployment
Following deployment, the balloon catheter is retracted into the
sheath. Paravalvular aortic insufficiency should be assessed with
TEE and/or aortography. If it is found to be significant, a repeat
dilatation of the valve with the same balloon can be performed
but must also be done under rapid ventricular pacing. These
Figure 9 Deep nconfirmatory imaging modalities can also help diagnose poten-tial problems such as coronary occlusion, dissection, or annular
disruption (Fig. 22; final aortography showing patent valve, in-
tegrity of cardiac boarders, and adequate coronary filling).
Remember, the stiff wire (if still in the aorta) may impinge
the valve leaflet and cause a central leak that will resolve on
wire removal.
Closure
Following deployment, the wire pulled back into the sheath
and the image intensifier is moved away to provide more
comfortable access to the surgical site.
For hemostatic considerations, the removal of the sheath may
be performed under a short interval of rapid ventricular pacing
and Protamine is given once gross hemostasis is achieved, ex-
cluding the need for cardiopulmonary bypass initiation. If sig-
nificant apical bleeding is encountered, this is typically best re-
paired by decompressing the ventricle with cardiopulmonary
bypass rather than placing additional “high-tension” sutures that
bites required.eedlemay further tear the ventricle. Loose re-approximation of the
Transapical transcatheter aortic valve implantation 51Figure 10 (A) Purse-string configuration on cardiac apex. (B) Ascendra balloon valvuloplasty catheter. (C) Ascendra
valve deployment catheter. (Color version of figure is available online at http://www.optechtcs.com.)
52 Y. Ben-Gal and M. WilliamsFigure 11 Correct valve orientation for TA-AVI.Figure 12 Needle and wire introduction.
Transapical transcatheter aortic valve implantation 53Figure 13 Wire advancement.
54 Y. Ben-Gal and M. WilliamsFigure 14 Introducer sheath advancement. (Color version of figure is available online at http://www.optechtcs.com.)
Transapical transcatheter aortic valve implantation 55Figure 15 Valvuloplasty balloon positioning. (A) White arrow demarcates calcified aortic valve. (B) Valvuloplasty.
56 Y. Ben-Gal and M. WilliamsFigure 16 Hemodynamic tracing dur-
ing valvuloplasty and also during
valve deployment.
Transapical transcatheter aortic valve implantation 57Figure 17 Valve loader.Figure 18 Loading the valve into introducer sheath.
58 Y. Ben-Gal and M. WilliamsFigure 19 Valve positioning.
Transapical transcatheter aortic valve implantation 59Figure 20 Fine positioning (after pusher rod retrieved into introducer).
60 Y. Ben-Gal and M. WilliamsFigure 21 Valve deployment in stages.
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Transapical transcatheter aortic valve implantation 61pericardium may help prevent erosion of the felt against the
chest wall and prevent a late pseudoaneurysm.
A small soft drain is left in the pleural space and the inter-
space is infiltrated with local anesthesia. Usually only the soft
tissues are closed and pericostal sutures are almost never
required as the thoracotomy is too anterior to allow any sig-
nificant excursion of the ribs.
Groin sheaths are removed and the vessels are sealed man-
ually or with a closure device. TVP may be left in place for an
Figure 22 Fextended period of time.Conclusions
Transapical aortic valve implantation is an emerging surgical
technique that is essentially different from other surgical pro-
cedures, necessitating an additional level of proficiency from
the surgeon along with a high level of coordination among
multidisciplinary team members. Proper patient selection,
synchrony, and communication of all operators along with
technical dexterity will afford good results for this high-risk
rtography.patient population.
